FDA inspection
SpecGx LLC: FDA inspection ending Feb 11, 2022
FDA inspection 1163660 · No Action Indicated (NAI) · Saint Louis, MO
Key facts
| Inspection ID | 1163660 |
|---|---|
| Firm | SpecGx LLC |
| FEI number | 1940521 |
| Address | 3600 N 2nd St |
| City | Saint Louis |
| State | MO |
| ZIP | 63147 |
| Country | United States |
| Fiscal year | 2022 |
| Inspection end date | Feb 11, 2022 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data